Achieve Life Sciences, Inc. Payments for Restructuring
Achieve Life Sciences, Inc. (ACHV) reported Payments for Restructuring of $2.07 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-07-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2017-07-31
- Achieve Life Sciences, Inc. payments for restructuring for the quarter ending 2017-06-30 was $19.00K.
- Achieve Life Sciences, Inc. payments for restructuring for the quarter ending 2017-03-31 was $2.05M.
- Achieve Life Sciences, Inc. payments for restructuring for fiscal 2016 was $708.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 12 month |
|---|---|---|---|
| 2017-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $2.07M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $2.05M 10-Q · filed 2017-05-15 | ||
| 2016-12-31 | $708.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |